Senyalització Oncogènica i del Desenvolupament
- Nombre de publicacions
- 129
Publicacions
-
Fuste, NP; Castelblanco, E; Felip, I; Santacana, M; Fernandez-Hernandez, R; Gatius, S; Pedraza, N; Pallares, J; Cemeli, T; Valls, J; Tarres, M; Ferrezuelo, F; Dolcet, X; Matias-Guiu, X; Gari, E
Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer
Oncotarget 7 26979-26991. .
-
Yeramian, A; Vea, A; Benitez, S; Ribera, J; Domingo, M; Santacana, M; Martinez, M; Maiques, O; Valls, J; Dolcet, X; Vilella, R; Cabiscol, E; Matias-Guiu, X; Marti, RM
2-phenylethynesulphonamide (PFT-) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels
PIGMENT CELL & MELANOMA RESEARCH 29 352-371. .
-
Mirantes, C; Dosil, MA; Hills, D; Yang, J; Eritja, N; Santacana, M; Gatius, S; Vilardell, F; Medvinsky, A; Matias-Guiu, X; Dolcet, X
Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies
BLOOD 127 1907-1911. .
-
Eritja, N; Arjo, G; Santacana, M; Gatius, S; Ramirez-Nunez, O; Arcal, L; Serrano, JCE; Pamplona, R; Dolcet, X; Pinol, C; Christou, P; Matias-Guiu, X; Portero-Otin, M
Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1862 526-535. .
-
Vaquero, M; Macia, A; Anerillas, C; Velasco, A; Matias-Guiu, X; Ribera, J; Encinas, M
Sprouty1 haploinsufficiency accelerates pheochromocytoma development in Pten(+/-) mice
ENDOCRINE-RELATED CANCER 23 7-11. .
-
Akita T; Kumada T; Yoshihara SI; Egea J; Yamagishi S
Ion channels, guidance molecules, intracellular signaling and transcription factors regulating nervous and vascular system development
Journal of Physiological Sciences 66 175-188. .
-
Bozic M; Álvarez Á; de Pablo C; Sanchez-Niño MD; Ortiz A; Dolcet X; Encinas M; Fernandez E; Valdivielso JM
Impaired Vitamin D Signaling in Endothelial Cell Leads to an Enhanced Leukocyte-Endothelium Interplay: Implications for Atherosclerosis Development
PLoS One 10 -. .
-
Eritja N; Santacana M; Maiques O; Gonzalez-Tallada X; Dolcet X; Matias-Guiu X
Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: Endometrial cancer as a model
METHODS 77-78 31-40. .
-
Alonso-Alconada, L.; Santacana, M.; Garcia-Sanz, P.; Muinelo-Romay, L.; Colas, E.; Mirantes, C.; Monge, M.; Cueva, J.; Oliva, E.; Soslow, R.A.; Lopez, M.A.; Palacios, J.; Prat, J.; Valls, J.; Krakstad, C.; Salvesen, H.; Gil-Moreno, A.; Lopez-Lopez, R.; Dolcet, X.; Moreno-Bueno, G.; Reventos, J.; Matias-Guiu, X.; Abal, M.
Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer
INTERNATIONAL JOURNAL OF CANCER 136 1863-1873. .
-
Espinet C; Gonzalo H; Fleitas C; Menal MJ; Egea J
Oxidative Stress and Neurodegenerative Diseases: A Neurotrophic Approach
CURRENT DRUG TARGETS 16 20-30. .
-
Alonso-Alconada L; Eritja N; Muinelo-Romay L; Barbazan J; Lopez-Lopez R; Matias-Guiu X; Gil-Moreno A; Dolcet X; Abal M
ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas
CARCINOGENESIS 35 2679-2686. .
-
Santacana M; Maiques O; Valls J; Gatius S; Abó AI; López-García MÁ; Mota A; Reventós J; Moreno-Bueno G; Palacios J; Bartosch C; Dolcet X; Matias-Guiu X
A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry
HUMAN PATHOLOGY 45 2394-2403. .
